Literature DB >> 13481251

Surface phagocytosis; further evidence of its destructive action upon fully encapsulated pneumococci in the absence of type-specific antibody.

M R SMITH, W B WOOD.   

Abstract

Experiments recently reported (18) have been interpreted to indicate that surface phagocytosis plays no significant part in natural antipneumococcal defense. A repetition of these experiments has revealed: (a) that the cellular content of the leucocytic suspensions used in the phagocytic tests was of a different order of magnitude from that of the exudates which usually exist in infected tissues, (b) that the suspensions were too dilute to allow surface phagocytosis of pneumococci to occur, and (c) that the ratio of bacteria to leucocytes. was such that, when a sufficiently concentrated exudate was employed, the pneumococci injured the leucocytes and thus prevented phagocytosis from taking place. When conditions of the tests were suitably controlled, and conventional quantitative methods were employed to measure the end results of the phagocytic reaction, the essential observations relating to surface phagocytosis were fully confirmed. The significance of this non-antibody mechanism of defense in pneumococcal infections was thus further substantiated.

Entities:  

Keywords:  DIPLOCOCCUS PNEUMONIAE; PHAGOCYTOSIS

Mesh:

Substances:

Year:  1958        PMID: 13481251      PMCID: PMC2136789          DOI: 10.1084/jem.107.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Resistance to bacteria in hemorrhagic shock. VII. Demonstration of leucotoxin in plasma of shocked rabbit.

Authors:  J FINE; S H RUTENBURG
Journal:  Proc Soc Exp Biol Med       Date:  1956-12

2.  Surface phagocytosis in vivo.

Authors:  M R SMITH; W D PERRY; J W BERRY; W B WOOD
Journal:  J Immunol       Date:  1951-07       Impact factor: 5.422

3.  An experimental analysis of the curative action of penicillin in acute bacterial infections. II. The role of phagocytic cells in the process of recovery.

Authors:  M R SMITH; W B WOOD
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307

4.  The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III.

Authors:  W B WOOD; M R SMITH
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

5.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

6.  The mechanisms by which macrophages phagocyte encapsulated bacteria in the absence of antibody.

Authors:  W D SAWYER; M R SMITH; W B WOOD
Journal:  J Exp Med       Date:  1954-10-01       Impact factor: 14.307

7.  Phagocytosis of bacteria in the absence of antibody and the effect of physical surface; a reinvestigation of surface phagocytosis.

Authors:  E M LERNER
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307

8.  Studies on the cellular immunology of acute bacteremia. I. Intravascular leucocytic reaction and surface phagocytosis.

Authors:  W B WOOD; M R SMITH; W D PERRY; J W BERRY
Journal:  J Exp Med       Date:  1951-12-01       Impact factor: 14.307

9.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood; E N Irons
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

10.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLADER'S BACILLUS : III. THE ROLE OF "SURFACE PHAGOCYTOSIS" IN THE DESTRUCTION OF THE MICROORGANISMS IN THE LUNG.

Authors:  M R Smith; W B Wood
Journal:  J Exp Med       Date:  1947-08-31       Impact factor: 14.307

View more
  12 in total

1.  Phagocytosis, with particular reference to encapsulated bacteria.

Authors:  W B WOOD
Journal:  Bacteriol Rev       Date:  1960-03

2.  [Mechanisms of nonspecific infection resistance].

Authors:  D BOHME
Journal:  Klin Wochenschr       Date:  1958-09-15

3.  A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).

Authors:  Kristopher R Genschmer; Mary Ann Accavitti-Loper; David E Briles
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

4.  Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro.

Authors:  J E Repine; C C Clawson; P S Friend
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

5.  Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins.

Authors:  M R Smith; H S Shin; W B Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

6.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

7.  Studies on the virulence of Neisseria gonorrhoeae. I. Relation of colonial morphology and resistance to phagocytosis by polymorphonuclear leukocytes.

Authors:  C Thongthai; W D Sawyer
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

8.  Heat labile opsonins to pneumococcus. I. Participation of complement.

Authors:  M R Smith; W B Wood
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

9.  Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.

Authors:  H S Shin; M R Smith; W B Wood
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

10.  Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis.

Authors:  R H Drachman; R K Root; W B Wood
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.